BioCardia, Inc. (BCDA)
Develops cell therapies to repair damaged hearts and treat heart failure.
$0.78-0.03%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-63.3%
The outlook
BCDA trades near its 52-week low, well below both its 50- and 200-day moving averages, reflecting a weak recent trend. Analyst coverage is sparse, but the average price target sits significantly above the current price. The overall tone among available data leans bearish.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Price targetAvg target +1884% vs current price
Analyst price target
~12-month · 2 analysts$15.50average target+1883.9% vs now
Now $0.78
Low $6.00High $25.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$11.6M
52-wk high
$2.32
52-wk low
$0.75
50-day avg
$0.95
200-day avg
$1.19
Trailing P/E
—